PharmNetOnline.com, Online Rx Sources
 

Nisoldipine Er 8.5mg Tablet

  Nisoldipine Er 8.5mg Tablet 30 Tablets $135.80
  Nisoldipine Er 8.5mg Tablet 60 Tablets $266.59
  Nisoldipine Er 8.5mg Tablet 90 Tablets $397.39
  Nisoldipine Er 8.5mg Tablet 120 Tablets $528.18
  Nisoldipine Er 8.5mg Tablet 180 Tablets $789.77
These are self-pay prices and do not take into account any discounts or prescription insurance coverage that you may have. Actual prices are calculated at the time your prescription is processed by the pharmacy.
Rx Prices Online
Find Alphabetically:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z#
Search:
Ordering Prescriptions
Online Resources

Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts.
Authors: Walsh KB, Zhang J, Fuseler JW, Hilliard N, Hockerman GH Cardiac voltage-gated Ca(2+) channels regulate the intracellular Ca(2+) concentration and are therefore essential for muscle contraction, second messenger activation, gene expression and electrical signaling. As a first step in accessing the structural versus functional properties of the L-type Ca(2+) channel in the heart, we have expressed a dihydropyridine (DHP)-insensitive Ca(V)1.2 channel in rat ventricular myocytes and fibroblasts. Following isolation and culture, cells were infected with adenovirus expressing either LacZ or a mutant Ca(V)1.2 channel (Ca(V)1.2DHP(i)) containing the double mutation (T1039Y Q1043M). This mutation renders the channel insensitive to neutral DHP compounds such as nisoldipine. The wh...div id=medwormpbiMedWorm Message:/i/b Please support the a href=http://www.doctorsinchains.org/ target=_blankDoctors In Chains/a campaign for the a href=http://www.doctorsinchains.org/medics/a tortured and sentenced for up to 15 years in a href=http://www.doctorsinchains.org/Bahrain/a. a href=https://twitter.com/#!/search/%23FreeDoctors#FreeDoctors/a/p/div

Robust, Durable Responses With Vedolizumab for UCRobust, Durable Responses With Vedolizumab for UC
DDW 2012: Data are considered 'fantastic' by late-breaking session moderators with the anti-TNF-alpha agent in treatment-resistant ulcerative colitis (UC). Medscape Medical News (Source: Medscape Today Headlines)